Blog

3 CDMO Trends Shaping Pharma in 2025: Insights from Our CCO, Henny Zijlstra

In a recent Contract Pharma roundtable, industry leaders discussed the key trends impacting CDMOs in 2025 and beyond. Our very own CCO, Henny Zijlstra, contributed her expertise to the conversation, highlighting three critical areas that CDMOs need to address this […]

Case Study: How a European Biopharma Entered Japan

How a Seamless Marketing Authorization Transfer Enabled a Swift Biopharma Launch in Japan When it comes to bringing high-value biopharmaceuticals to new markets, meticulous planning and flawless execution are essential. This is especially true for products as complex as monoclonal […]

Subscribe to our newsletter!

Get notified on our latest news.